Neural damage and inflammation in myotonic dystrophy type 1: Longitudinal analysis of serum NFL, GFAP, and IL-6
Year: 2025
Type: article
Language: en
Topic: Genetic Neurodegenerative Diseases
Authors and affiliations:
raw_author_name: Joana Garmendia
raw_affiliation_strings: Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Institute Carlos III, Madrid, Spain; Department of Clinical and Health Psychology and Research Methodology, University of the Basque Country (UPV/EHU), Donostia-San Sebastián, Gipuzkoa, Spain
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Institute Carlos III, Madrid, Spain
raw_author_name: Garazi Labayru
raw_affiliation_strings: Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Institute Carlos III, Madrid, Spain; Department of Clinical and Health Psychology and Research Methodology, University of the Basque Country (UPV/EHU), Donostia-San Sebastián, Gipuzkoa, Spain; Neurosciences Area, Instituto Biodonostia, San Sebastian, Spain
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Institute Carlos III, Madrid, Spain; Department of Clinical and Health Psychology and Research Methodology; Psychology Faculty, University of the Basque Country (UPV/EHU), Donostia-San Sebastián, Gipuzkoa, Spain; Neurosciences Area, Instituto Biodonostia, San Sebastian, Spain
raw_author_name: Ainhoa Alberro
raw_affiliation_strings: Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Institute Carlos III, Madrid, Spain; Neuroimmunology Group, Biogipuzkoa Health Research Institute, P/ Doctor Begiristain s/n, Donostia-San Sebastián, Spain
raw_author_name: Laura Martins-Almeida
raw_affiliation_strings: Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Institute Carlos III, Madrid, Spain; Neuroimmunology Group, Biogipuzkoa Health Research Institute, P/ Doctor Begiristain s/n, Donostia-San Sebastián, Spain
raw_author_name: David Otaegui
raw_affiliation_strings: Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Institute Carlos III, Madrid, Spain; Neuroimmunology Group, Biogipuzkoa Health Research Institute, P/ Doctor Begiristain s/n, Donostia-San Sebastián, Spain
raw_author_name: Pablo Iruzubieta
raw_affiliation_strings: Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Institute Carlos III, Madrid, Spain; Neurology Department, Donostia University Hospital-OSAKIDETZA, Donostia-San Sebastián, Gipuzkoa, Spain; Neurogenetics, RNA Biology and Therapies Group, Neurosciences Area, Biogipuzkoa Health Research Institute, San Sebastian 20014, Spain; Department of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, QC H3A 2B4, Canada
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Institute Carlos III, Madrid, Spain; Neurology Department, Donostia University Hospital-OSAKIDETZA, Donostia-San Sebastián, Gipuzkoa, Spain; Neurogenetics, RNA Biology and Therapies Group, Neurosciences Area, Biogipuzkoa Health Research Institute, 20014 San Sebastian, Spain; Department of Neurology and Neurosurgery, Montreal Neurological Hospital and Institute, McGill University, Montreal, QC H3A 2B4, Canada
raw_author_name: Adolfo Lopez de Munain
raw_affiliation_strings: Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Institute Carlos III, Madrid, Spain; Neurosciences Area, Instituto Biodonostia, San Sebastian, Spain; Neurology Department, Donostia University Hospital-OSAKIDETZA, Donostia-San Sebastián, Gipuzkoa, Spain; Department of Neurosciences, Faculty of Medicine and Nursery, University of the Basque Country, San Sebastián, Spain; Department of Medicine, Faculty of Health Sciences, University of Deusto, Bilbao, Bizkaia, Spain
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Institute Carlos III, Madrid, Spain; Neurosciences Area, Instituto Biodonostia, San Sebastian, Spain; Neurology Department, Donostia University Hospital-OSAKIDETZA, Donostia-San Sebastián, Gipuzkoa, Spain; Department of Neurosciences. Faculty of Medicine and Nursery, University of the Basque Country, San Sebastián, Spain; Department of Medicine, Faculty of Health Sciences, University of Deusto, Bilbao, Bizkaia, Spain
raw_author_name: Andone Sistiaga
raw_affiliation_strings: Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Institute Carlos III, Madrid, Spain; Department of Clinical and Health Psychology and Research Methodology, University of the Basque Country (UPV/EHU), Donostia-San Sebastián, Gipuzkoa, Spain; Neurosciences Area, Instituto Biodonostia, San Sebastian, Spain. Electronic address: andone.sistiaga@ehu.eus
Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Institute Carlos III, Madrid, Spain; Department of Clinical and Health Psychology and Research Methodology; Psychology Faculty, University of the Basque Country (UPV/EHU), Donostia-San Sebastián, Gipuzkoa, Spain; Neurosciences Area, Instituto Biodonostia, San Sebastian, Spain. Electronic address: andone.sistiaga@ehu.eus